返回 Agenda
Topic 2 Session 5 cont: Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies
Speaker(s)
Gaby L. Danan, MD, PHD
GLD, France
Pharmacovigilance Expert
Holiday Inn London Kensington Forum
2016 年 11 月 14 日 8:00 上午 - 2016 年 11 月 18 日 1:30 下午
97 Cromwell Road, London, SW7 4DN, United Kingdom
Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing
The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.